• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Women in Nutraceuticals Names Global Lead in India Ahead of Nutrify C-Suite Summit

    Batory Foods Acquires Tri-State Companies

    Blue Diamond, Brightseed Partner To Discover New Almond Bioactives

    GOED Publishes Report on EPA and DHA’s Impact on Brain Health

    Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Blue Diamond, Brightseed Partner To Discover New Almond Bioactives

    GOED Publishes Report on EPA and DHA’s Impact on Brain Health

    Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics

    Reproductive Factors, Menopause Play Understated Role in Heart Health Risk

    Sempera Organics and Alkemist Labs Announce Partnership for Mushroom Testing
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Women in Nutraceuticals Names Global Lead in India Ahead of Nutrify C-Suite Summit

    Batory Foods Acquires Tri-State Companies

    Blue Diamond, Brightseed Partner To Discover New Almond Bioactives

    GOED Publishes Report on EPA and DHA’s Impact on Brain Health

    Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Women in Nutraceuticals Names Global Lead in India Ahead of Nutrify C-Suite Summit

    GOED Publishes Report on EPA and DHA’s Impact on Brain Health

    Reproductive Factors, Menopause Play Understated Role in Heart Health Risk

    Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient

    Nootropic Shown to Support Mental Alertness, Focus, Attention
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Premium Labels & Packaging Solutions

    Botanic Healthcare LLC

    JRS Pharma

    BGG Americas, Inc.

    Gencor
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Premium Labels & Packaging Solutions

    Botanic Healthcare LLC

    JRS Pharma

    BGG Americas, Inc.

    Gencor
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act

    Daniel Fabricant, NPA president and CEO, lays out ‘grave concerns’ with mandatory product listing bill in message to Sens. Durbin and Braun.

    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    By Mike Montemarano, Associate Editor04.29.22
    Following introduction of the Dietary Supplement Listing Act, which seeks to establish a mandatory product listing (MPL) for dietary supplements sold in the U.S., Natural Products Association (NPA) president and CEO Daniel Fabricant, PhD, submitted a letter to the bill’s sponsors, Senators Dick Durbin (D-IL) and Mike Braun (R-IN).

    Fabricant expressed the association’s opposition and “grave concerns” regarding the impact that MPL would have on the marketplace.

    NPA directly opposes MPL, considering it “pre-market approval” that presents an undue burden on dietary supplement companies, as Fabricant said when FDA requested modernization to the Dietary Supplement Health and Education Act (DSHEA) in its FY2023 budget request.

    NPA: MPL Will Not Benefit Reputable Companies
    In NPA’s letter to Durbin and Braun, Fabricant, who served as director of the Division of Dietary Supplement Programs (now an Office at NIH) from 2011 to 2014, outlined a series of potential negative impacts that MPL would have on the dietary supplements industry.

    “I can tell you during my time as the chief regulator for dietary supplements when we had some of the most impactful enforcement actions in the program’s history, we had more than adequate tools to find a specific problem with a product or ingredient. To reiterate, we had no problem ‘seeing’ into industry and addressing issues when they arose.”

    The industry already provides plenty of information to FDA about products and ingredients, Fabricant continued. “Unfortunately, FDA fails to use this information currently. Are there any plans to understand the transparency behind this?”

    While introducing the bill on the Senate floor on Apr. 26, Durbin called attention tianeptine, an unapproved drug in the U.S. that had been found in adulterated products marketed as dietary supplements in 2018. FDA sent Warning Letters to two companies in November that year, but according to a Consumer Reports article, the agency knew of these products for 9 months before taking action.

    Fabricant and NPA argued that the Durbin-Braun bill would not solve problems like tianeptine, which was marketed and sold by criminals who would not have voluntarily filed information with FDA.

    “This legislation would not address that issue or the failures of the FDA. Furthermore, the sellers of tianeptine are criminal drug traffickers,” Fabricant said. “Criminals do not report their illegal activity to the government. Finally, the makers and sellers of tianeptine will not add their products to a mandatory product listing so the FDA can ‘see’ where they are and what they’re up to. Even if they sent their labels to FDA, the FDA would still be required to take enforcement action. However, recently, there has been a historical pattern of inactivity and misaligned priorities by the FDA.”

    Objections
    Overall, Fabricant said the Dietary Supplement Listing Act would reduce government accountability in several ways: 

    MPL would offer FDA an administrative tool to remove anything it believed isn’t a dietary ingredient from the marketplace, even in instances “where they have applied the law inappropriately or incorrectly.” Fabricant offered CBD/cannabinoids, N-acetyl-L-cysteine, and several probiotics as potential examples.

    The legislation would delay market access for new and safe supplements, and increase supplement prices while divesting resources from facility inspections, which have not returned to pre-COVID levels.

    This divestment would “harm consumer safety by leading to fewer FDA inspections and enforcement actions,” Fabricant wrote. “The agency has clearly demonstrated that it is unable or unwilling to do the vital work that Congress has already authorized it to carry out.”

    Additionally, the bill would “impose a hefty new tax” on supplement companies, saddling other stakeholders with a “new and unnecessary regulatory burden,” Fabricant said. “This would pour gas on the inflationary fire for products that Americans use every day, especially hitting low-income consumers and those on fixed incomes the hardest.”

    Essentially, the legislation would reward criminals that ignore MPL requirements, offering them a “significant market edge” over reputable, law-abiding companies. Bad actors could also create “cheap imitation products with illegal substances,” he argued, while legitimate brands await FDA approval.

    Fabricant also said the bill would “impose an unfair burden on dietary supplements” compared to foods and beverages fortified with many of the same nutrients found in supplement form.

    Lastly, “Prior legislation dealing with FDA authority on supplements and other related industries has always provided for pre-emption of the states. This bill with a proposed public-facing list will be used most frequently by plaintiff’s attorneys looking to bring meaningless nuisance lawsuits against the industry. The industry needs one regulator, not 51,” Fabricant argued.

    Prioritize Inspections
    Citing Office of the Inspector General data which demonstrated that food facility inspections conducted by the FDA have been on the decline, Fabricant suggested that FDA focus on ramping up inspections, as it is mandated to do by the Food Safety Modernization Act (FSMA).

    “In 2017, the Office of the Inspector General published a report about the agency’s progress toward food facility inspection goals. The annual number of food facilities inspected dropped from 29% in 2004 to 19% in 2015. The report highlighted that despite increasing spending for domestic food facility inspections, the number of reviews proportionately decreased. This was five years before the global pandemic, but inspections continue to drop further,” Fabricant said. “The same Office of Inspector General report also analyzed FDA’s follow-up inspectional findings. The report highlighted that the agency ‘often took no action in response to significant inspection violations.’”

    FDA Already has Enough Tools
    Fabricant’s letter characterized FDA’s existing enforcement authority as sufficient enough to remove harmful or illegal products from the marketplace in a timely manner.

    New Dietary Ingredient (NDI) Notifications, which companies are required to submit to FDA 75 days before entering commerce, covers all ingredients that are not currently approved for use in dietary supplements. “What is proposed is legislation that would require companies marketing products with ‘old dietary ingredients’ such as vitamins and minerals but with a new flavor to get FDA approval via a listing before entering the market,” Fabricant said. “This is an excessive administrative burden” that exceeds current scientific safety evaluations.

    Additionally, the Food, Drug, and Cosmetic Act already requires companies to submit details about structure/function claims prior to adding them to product labels, no later than 30 days after marketing said dietary supplement. Fabricant described this as a redundancy, given that FDA maintains a database of structure/function claims. “FDA never stated why these submissions can’t be used as an enforcement tool,” Fabricant noted.

    Companies are also required to file any and all serious adverse event reports (SAERs) associated with dietary supplement products.

    “The FDA already has access to information regarding who is making dietary supplements, where they are making them, what products are made at which facilities, when new ingredients are introduced into commerce, and whether any products are associated with serious adverse events,” Fabricant’s letter said. In addition, the Office of Dietary Supplement Programs at the NIH already maintains a Dietary Supplement Label Database, he noted, calling for more support to the ODSP and a budget that increases enforcement actions spelled out in DSHEA.

    “As proposed, there are only two primary winners/benefactors of this so-called transparency of mandatory product listing. First, are disreputable individuals looking to create counterfeit products based on the ingredients and formulations in the database submitted by legitimate companies, hoping they can turn a quick profit with imitation products likely comprised of illicit ingredients. The second is the plaintiff bar, which would eagerly pull in as many companies as possible into class-action lawsuits based on alleged injuries caused by foods or supplements.”
    Related Searches
    • Regulations
    • Dietary Supplements
    Related Knowledge Center
    • Regulations
    • Dietary Supplements
    Suggested For You
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars
    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    Understanding FTC’s Warning to Industry: Considerations for the Natural Products Industry Understanding FTC’s Warning to Industry: Considerations for the Natural Products Industry
    CRN Petitions FDA to Change Course on CRN Petitions FDA to Change Course on 'Drug Preclusion'
    Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims
    FTC Issues Notice to Hundreds of Companies About Health-Claims Substantiation FTC Issues Notice to Hundreds of Companies About Health-Claims Substantiation
    What the Modernization of Cosmetics Regulation Act Means for Hemp and CBD Cosmetic Manufacturers What the Modernization of Cosmetics Regulation Act Means for Hemp and CBD Cosmetic Manufacturers
    Core Work: Gut Health as the Center of Wellness Core Work: Gut Health as the Center of Wellness
    Products Featuring Sustainability Claims Gain Greater Share of Consumer Spending Products Featuring Sustainability Claims Gain Greater Share of Consumer Spending
    Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision Disappearing Act: The Battle Over Dietary Supplement Ingredients and the Drug Exclusion Provision
    Idaho Bill Advances to Preserve Legal Status of Dietary Supplements Idaho Bill Advances to Preserve Legal Status of Dietary Supplements
    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway? CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
    2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy 2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy
    The Top 10 Articles of 2022 on NutraceuticalsWorld.com The Top 10 Articles of 2022 on NutraceuticalsWorld.com

    Related Features

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Immune Function | Quality & Safety | Testing
      A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

      A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

      The mushroom renaissance has led to diverse product development, as stakeholders construct a long runway for future innovation.
      By Sean Moloughney, Editor 06.01.23

    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Pet Nutraceuticals | Quality & Safety | Regulations | Research | Testing
      The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

      The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

      The pandemic compelled many people to add a furry friend to their family, and their spending habits demonstrate a dedication to health.
      By Sean Moloughney, Editor 05.30.23

    • Dietary Supplements | Regulations
      Understanding FTC’s Warning to Industry: Considerations for the Natural Products Industry

      Understanding FTC’s Warning to Industry: Considerations for the Natural Products Industry

      Notices are seen as a maneuver after the Supreme Court ruled FTC can no longer use Section 13(b) of the FTC Act to collect fines from first-time offenders.
      By James Gormley, Gormley NPI Consulting 05.22.23


    • Breaking News | Dietary Supplements | Industry & Market News | Regulations | Regulatory News
      CRN Petitions FDA to Change Course on

      CRN Petitions FDA to Change Course on 'Drug Preclusion'

      CRN asked for clearer and more consistent application of the statute which prohibits ingredients from dietary supplements due to past drug research.
      By Mike Montemarano, Associate Editor 05.10.23

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Minerals | Proteins, Peptides, Amino Acids | Quality & Safety | Regulations | Testing | Vitamins
      Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims

      Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims

      The Council for Responsible Nutrition's president and CEO also reflected on the association's 50th anniversary, its values, and priorities.
      Sean Moloughney, Editor 04.28.23

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Nektium Expands International Distribution Network For Botanical Extracts
    Breaking News
    • Women in Nutraceuticals Names Global Lead in India Ahead of Nutrify C-Suite Summit
    • Batory Foods Acquires Tri-State Companies
    • Blue Diamond, Brightseed Partner To Discover New Almond Bioactives
    • GOED Publishes Report on EPA and DHA’s Impact on Brain Health
    • Alkemist Labs Creates Validated Method for Plant and Fungi-Based Psychedelics
    View Breaking News >
    CURRENT ISSUE

    June 2023

    • Functional Beverage Market Shakes Things Up with Formulation Breakthroughs
    • A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars
    • The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    • (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands
    • Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    • KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Names Global Lead in India Ahead of Nutrify C-Suite Summit
    Batory Foods Acquires Tri-State Companies
    Blue Diamond, Brightseed Partner To Discover New Almond Bioactives
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel to Supply Porsche China with Complete Water-Based Refinish Range
    Evonik Earns ACC’s Sustainability Leadership Award
    Sandrine Garnier Joins ChemQuest as a Director
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—June 10
    Merit Medical Acquires AngioDynamics' Catheter Portfolio
    iCAD Strengthens Leadership Team
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Quell Therapeutics, AstraZeneca Partner on Engineered Treg Cell Therapies
    Charles River, INADcure Collaborate on Gene Therapy Manufacturing
    Lotus Clinical Research, Trialogics Partner for Clinical Trial Software Services
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Guerlain's 'Secret' Archive—the World's 1st Lipstick, Perfume, & Nivea Jar
    Mary Kay Supports Ocean Conservation & Coral Reef Protection
    TerraCycle and Wrinkles Schminkles Announce Recycling Program
    Happi

    Latest Breaking News From Happi

    Itiah Angels Charity Seeks Cosmetics Donations
    Scent Theory and Crayola Partners to Establish New Hand Soap Collection
    Givaudan Active Beauty Names Agathe Parent New Communication Manager
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Steve Billow, Kodak, Doneck Euroflex Top This Week’s Stories
    ITMA 2023 Opens with Mega Showcase of Innovative Solutions
    Kornit Digital Shows Enhanced Presto MAX at ITMA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWT Labels & Packaging acquires ASL Print FX
    Avery Dennison announces new cohort of startups for AD Stretch Accelerator Program
    Appvion unveils new film label facestock
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Rascal + Friends Expands Distribution with Walmart
    ITMA ASIA + CITME Announce Second Location
    Andritz Partnership with Pellenc ST and Nouvelles Fibres Enters New Phase
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—June 10
    SurGenTec's TiLink-L SI Joint Implant Gains FDA Nod
    Orthopedic Prosthetic Market to Eclipse $3.39 Billion by 2030
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Francisco Melo, GlobalFoundries and STMicro Top This Week’s Stories
    Sensirion Air Quality Sensors Harmonized with RESET Air Standard
    Identiv Introduces Industry’s First Battery-Free Metal Sensor IoT Devices

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login